Navigation Links
Telik Announces Financial Results For 2008 Second Quarter
Date:8/11/2008

idates or any product that Telik may develop, or obtain marketing approval before Telik does, Telik's commercial opportunity will be reduced or eliminated, and if Telik does not obtain regulatory approval to market products in the U.S. and foreign countries, Telik will not be permitted to commercialize its product candidates. Detailed information regarding factors that may cause actual results to differ materially from the results expressed or implied by statements in this press release may be found in Telik's periodic filings with the Securities and Exchange Commission, including the factors described in the section entitled "Risk Factors" in its quarterly report on Form 10-Q for the quarter ended March 31, 2008. Telik does not undertake any obligation to update forward-looking statements contained in this press release.

TELIK, the Telik logo, TELINTRA, TELCYTA and TRAP are trademarks or registered trademarks of Telik, Inc.

Telik, Inc.

Statements of Operations

(In thousands, except per share amounts)

(Unaudited)

Three Months Ended Six Months Ended

June 30, June 30,

2008 2007 2008 2007

Operating costs and expenses:

Research and development $8,236 $11,869 16,431 $24,813

General and administrative 2,773 3,979 5,186 7,631

Restructuring costs - (33) - 1,356

Total operating costs and

expenses 11,009 15,815 21,617 33,800

Loss from operations (11,009) (15,815) (21,617) (33,800)

Interest and other income

(expense), net (2,560) 1,492 (1,760) 3,155

Net loss
'/>"/>

SOURCE Telik, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Telik Announces 2008 Second Quarter Financial Release, Conference Call and Webcast
2. Telik Announces Publication of Diabetes Research in Bioorganic & Medicinal Chemistry Letters
3. Telik Announces Presentation and Webcast at Needham Biotechnology Conference
4. Telik Announces First Quarter 2008 Financial Results
5. Telik Presents Preclinical Data at 99th Annual Meeting of the American Association for Cancer Research
6. Telik Announces Fourth Quarter and 2007 Year End Financial Results and 2008 Guidance
7. Telik Announces Revised Date for Year-End Financial Release, Conference Call and Webcast
8. Telik Announces Year-End Financial Release, Conference Call and Webcast
9. Telik Announces Presentation and Webcast at JPMorgan Healthcare Conference
10. Telik Announces Presentation and Webcast at UBS Global Life Sciences Conference
11. Telik Announces Presentation and Webcast at Bear Stearns Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... December 23, 2014 The ... such as its definition, classification, application and ... specification, manufacturing process, and product cost structure. ... applications. The analysis also covers upstream raw ... industry development trend and proposals. In the ...
(Date:12/24/2014)... BEIJING , Dec. 23, 2014 ... or the "Company"), a leading fully integrated plasma-based ... today announced that its majority-owned subsidiary, Shandong Taibang ... Practices ("GMP") certification from the China Food and ... factor production facility. As previously disclosed in the ...
(Date:12/24/2014)... 2014  Rock Creek Pharmaceuticals, Inc., (NASDAQ: ... Clinical Trial Application (CTA) with the United ... seeking regulatory approval to initiate clinical trials for the ... Contingent on the Company receiving CTA regulatory approval, ... to assess the safety, tolerability and dose escalation of ...
(Date:12/22/2014)... RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSX.V: RP), a ... of autologous cell therapies, announced today the publication of ... conjunction with co-authors from Kyoto University and the University ... clinical research using dermal sheath cup (DSC) cells to ... paper entitled " Hair Follicle Dermal Stem Cells Regenerate ...
Breaking Biology Technology:Worldwide Methyl Mercaptan Market 2015-2020 Forecasts on Development & Trends Now Available at ReportsnReports.com 2China Biologic Receives GMP Certification for New Coagulation Factor Facility 2China Biologic Receives GMP Certification for New Coagulation Factor Facility 3Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 2Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 3Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 2Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 3Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 4Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 5
... Inc., the leader in room temperature sample storage and ... Robb to the Scientific Advisory Board. ... with over 45 years experience in the fields of ... a Governor of the College of American Pathologists, an ...
... - May 25, 2011 - Semiconductor Research,Corporation ... and related technologies, and researchers from the,UCLA ... Science have,developed a new method of design-dependent ... promises to provide,semiconductor chip manufacturing cost and ...
... 11 earthquake and rolling blackouts that are severely affecting ... program NanoJapan is scrambling to run its annual summer ... to Japan for lab internships, NanoJapan is offering partner ... to Rice University laboratories for three months. "This ...
Cached Biology Technology:Biomatrica Announces the Appointment of Dr. James A. Robb as a Member of the Scientific Advisory Board 2Biomatrica Announces the Appointment of Dr. James A. Robb as a Member of the Scientific Advisory Board 3SRC and UCLA advance design-dependent process monitoring for semiconductor wafer manufacturing 2Reverse NanoJapan: Rice to host 25-30 Japanese students 2
(Date:12/22/2014)... Conn. , Dec. 22, 2014  NXT-ID, Inc. ... the "Company"), a biometric authentication company focused on the ... pickpocket, entertainer and security consultant, Apollo Robbins ... biometric smart wallet.  Apollo Robbins ... and 7 th , 2015, demonstrating some of his ...
(Date:12/19/2014)...  23andMe, Inc., the leading personal genetics company, today ... differences in genetic ancestry of individuals from across ... immigrants first arrived more than four hundred years ago, ... as a meeting place for peoples from different continents. ... mixing of peoples with African, European, and American origins ...
(Date:12/17/2014)... , Dec. 16, 2014 Valencell, a ... its PerformTek biometric technology to industry leaders such as ... accurate, clinically validated, biometric wearable products. These products will ... in Las Vegas . ... is accurate, flexible and robust – with the clinical ...
Breaking Biology News(10 mins):NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 2NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 3NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 423andMe Study Sketches Genetic Portrait of the United States 223andMe Study Sketches Genetic Portrait of the United States 323andMe Study Sketches Genetic Portrait of the United States 4Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2
... free throws don't quite turn out the same way each time, ... mostly in your head. That's the finding of new research published ... engineers at Stanford University. , "The main reason you can't move ... golf club, is that your brain can't plan the swing the ...
... first known laboratory studies that explores memory deficits associated ... Mayo Clinic researchers have evidence that this infection can ... which was conducted in animal models, suggests that over ... possibly have a permanent effect on memory late in ...
... scientists have identified a cell population that is a ... frontotemporal dementia, which is as common as Alzheimer's disease ... , Because the cells arose only recently in evolutionary ... and humans-- and are particularly abundant in humans, and ...
Cached Biology News:On the golf tee or pitcher's mound, brain dooms motion to inconsistency 2On the golf tee or pitcher's mound, brain dooms motion to inconsistency 3Mayo Clinic study suggests that a central nervous system viral infection can lead to memory deficits 2Mayo Clinic study suggests that a central nervous system viral infection can lead to memory deficits 3Study offers window into human behavior, brain disease 2Study offers window into human behavior, brain disease 3Study offers window into human behavior, brain disease 4
BD BioCoat Collagen I 35 mm Culture Dishes, tissue-culture treated polystyrene with a uniform application of rat tail collagen type I....
... Mouse Antibody to Human Cytokeratin TYPE II ... (Type II) keratins. Including epidermal cell keratin ... 58kD, 65kD and 67kD. Broad keratin reactivity ... and cornea. Immunogen: ...
... System is intended for use in the ... an in-house validated method for in vitro ... of interest. • ... hybridization capture assay designed to detect amplified ...
... culture scale-up, these culture chambers produce cell ... 9 range and are useful alternatives ... • High mechanical • strength and structural ... shipping • Certified nonpyrogenic and sterilized by ...
Biology Products: